Khiron Life Sciences Corp. (“Khiron”) announced that, in connection with its previously announced overnight marketed offering, A.G.P./Alliance Global Partners (“AGP”) has agreed to sell 27,435,000 units of the Company at a price of $0.45 per Unit for gross proceeds of $12,345,750 (the “Offering”). ATB Capital Markets Inc. (“ATB”) acted as co-placement agent to AGP in connection with the offering. Each Unit will consist of one common share (a “Unit Share”) and one common share purchase warrant of the Company. Each Warrant will entitle the holder thereof to acquire one Common Share (“Warrant Share”) at an exercise price of $0.75 per Warrant Share at any time prior to 5:00 p.m. on November 26, 2025. The proposed Offering is expected to close on or about July 8, 2021, subject to the satisfaction of customary closing conditions and the receipt of regulatory approvals, including the approval of the TSX Venture Exchange.

Published Ncv Newswire, New Cannabis Ventures, 07/06/2021 09:12:00

Open article: